| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antihepatitis B response to hepatitis B vaccine administered simultaneously with tetanus toxoid in nonresponder individuals
|
Sönmez, Emine
|
|
2002
|
21 |
3-4 |
p. 243-246
4 p.
|
artikel
|
| 2 |
A randomized, placebo-controlled trial of subcutaneous administration of GM-CSF as a vaccine adjuvant: effect on cellular and humoral immune responses
|
Somani, Jyoti
|
|
2002
|
21 |
3-4 |
p. 221-230
10 p.
|
artikel
|
| 3 |
Candidate peptide vaccine induced protection against classical swine fever virus
|
Dong, Xiao-Nan
|
|
2002
|
21 |
3-4 |
p. 167-173
7 p.
|
artikel
|
| 4 |
Combined intrarectal/intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette–Guérin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen
|
Kawahara, Mamoru
|
|
2002
|
21 |
3-4 |
p. 158-166
9 p.
|
artikel
|
| 5 |
Comparative evaluation of a combined DTP–HB vaccine in the EPI in Chiangrai Province, Thailand
|
Chunsuttiwat, Supamit
|
|
2002
|
21 |
3-4 |
p. 188-193
6 p.
|
artikel
|
| 6 |
Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly
|
Fry, Alicia M
|
|
2002
|
21 |
3-4 |
p. 303-311
9 p.
|
artikel
|
| 7 |
Cost-effectiveness of hepatitis B vaccination of prison inmates
|
Pisu, Maria
|
|
2002
|
21 |
3-4 |
p. 312-321
10 p.
|
artikel
|
| 8 |
DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice
|
López-Fuertes, L
|
|
2002
|
21 |
3-4 |
p. 247-257
11 p.
|
artikel
|
| 9 |
Editorial Board/Aims and Scope
|
|
|
2002
|
21 |
3-4 |
p. IFC-
1 p.
|
artikel
|
| 10 |
Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats
|
Burkhard, Mary Jo
|
|
2002
|
21 |
3-4 |
p. 258-268
11 p.
|
artikel
|
| 11 |
Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites
|
Edelman, Robert
|
|
2002
|
21 |
3-4 |
p. 269-280
12 p.
|
artikel
|
| 12 |
Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus
|
Matsui, Masanori
|
|
2002
|
21 |
3-4 |
p. 211-220
10 p.
|
artikel
|
| 13 |
Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules—potential benefits in vaccine design
|
Herrera, Osquel Barroso
|
|
2002
|
21 |
3-4 |
p. 231-242
12 p.
|
artikel
|
| 14 |
Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates
|
Stittelaar, Koert J
|
|
2002
|
21 |
3-4 |
p. 155-157
3 p.
|
artikel
|
| 15 |
Post-licensure comparative study of unusual high-pitched crying and prolonged crying following COMVAX™ and placebo versus PedvaxHIB™ and RECOMBIVAX HB™ in healthy infants
|
Kaplan, Karen M
|
|
2002
|
21 |
3-4 |
p. 181-187
7 p.
|
artikel
|
| 16 |
Reactogenicity and immunogenicity of a live attenuated tetravalent measles–mumps–rubella–varicella (MMRV) vaccine
|
Nolan, Terry
|
|
2002
|
21 |
3-4 |
p. 281-289
9 p.
|
artikel
|
| 17 |
Safety and efficacy of E. coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori
|
Sougioultzis, Stavros
|
|
2002
|
21 |
3-4 |
p. 194-201
8 p.
|
artikel
|
| 18 |
The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI)
|
Bonhoeffer, Jan
|
|
2002
|
21 |
3-4 |
p. 298-302
5 p.
|
artikel
|
| 19 |
The generation and characterization of potentially therapeutic Aβ antibodies in mice: differences according to strain and immunization protocol
|
Spooner, Edward T
|
|
2002
|
21 |
3-4 |
p. 290-297
8 p.
|
artikel
|
| 20 |
The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis
|
Alimohammadian, Mohammad Hossein
|
|
2002
|
21 |
3-4 |
p. 174-180
7 p.
|
artikel
|
| 21 |
The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults
|
Evans, Thomas G
|
|
2002
|
21 |
3-4 |
p. 322-329
8 p.
|
artikel
|
| 22 |
Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus
|
Arribillaga, Laura
|
|
2002
|
21 |
3-4 |
p. 202-210
9 p.
|
artikel
|
Tijdschrift beschrijving